Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Generex Biotechnology Corp. (GNBTQ) Message Board

The purpose of an IPO is to generate capital. Joe

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 36566
(Total Views: 440)
Posted On: 07/31/2020 1:24:33 PM
Posted By: Assiduous
The purpose of an IPO is to generate capital. Joe said he wants initially $50 million for NGIO. According to the10Q https://www.sec.gov/Archives/edgar/data/10597...orm10q.htm the total NGIO shares are 750 million, 350 million as treasury stock (shares) and 400 million as outstanding. “As of April 30, 2020, 400,000,000 shares of NGIO are issued and outstanding of which 38,357,038 shares belong to non-controlling interest shareholders which represents a 9.59% non-controlling interest.” Shares we got free as a dividend payout. GNBT owns the rest of the stock. If the IPO is set at $5, only10 million offered shares would be needed to generate the $50 million capital. With shares sold from the 350M treasury, the non GNBT shares increase to 48+ million. The important thing will be; NGIO will be a public company, NGIO will have $50M in capital for developing their initiatives, and we will have stock liquidity.

If my above reasoning is correct, then NGIO will still have 340M treasury shares to sell for future capital and GNBT will have, on paper at $5/share, $1,808,214,810 worth of NGIO stock. I would think that with this much paper value, the GNBT price should rise to at least NASDAQ qualification. This should be no different than as if an intuitional investor (Vanguard, Blackrock, etc.) held the NGIO stock. Side thought/question; with NGIO not being a subsidiary of GNBT but an independent company, could GNBT infuse NGIO with additional capital, if needed, with money made by selling some of NGIO shares they hold? Obviously GNBT could raise capital by selling some of their NGIO position.

It looks to me that the role of Oasis Capital https://www.sec.gov/Archives/edgar/data/18045...form8k.htm in the IPO, is to insure that a $5 minimum share price is maintained by buying up to the $50 million need for the NGIO capital infusion. Since I have never dealt with “futures”, how the “puts” calculations in the Oasis agreement is a mystery to me. So the earlier statement could be completely a misunderstanding on my part.


(3)
(0)




Generex Biotechnology Corp. (GNBTQ) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us